miRNA nanoencapsulation to regulate the programming of the blood-brain barrier permeability by hypoxia

Central nervous system (CNS)-related diseases are difficult to treat as most therapeutic agents they cannot reach the brain tissue, mainly due to the blood-brain barrier (BBB), arguably the tightest barrier between the human body and cerebral parenchyma, which routinely excludes most xenobiotic ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Figueroa, Esteban G., Caballero-Román, Aitor, Ticó, Josep R., Miñarro, Montserrat, Nardi-Ricart, Anna, González-Candia, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780061/
https://www.ncbi.nlm.nih.gov/pubmed/36568262
http://dx.doi.org/10.1016/j.crphar.2022.100129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780061/
https://www.ncbi.nlm.nih.gov/pubmed/36568262
http://dx.doi.org/10.1016/j.crphar.2022.100129

Ejemplares similares